TRANSDERMAL DRUG DELIVERY RESOURCES

• Procuring Packaging And Delivery Systems: Single Versus Dual Sourcing

  In this article, Fran DeGrazio examines the trend toward dual sourcing of products, components, and materials for drug delivery packaging and systems. She outlines the key differences between single and dual sourcing and makes recommendations about using one versus the other while mitigating supply chain and product quality risk. 

• How Dermal Delivery Platforms Are Transforming Tomorrows For Patients

  Skin delivery platforms expand therapies by boosting convenience, stability, and adherence. Integrated formulation, device, and manufacturing development is key to confidently scale.

• Combination Products: Market Trends And Regulatory Considerations

  Combination products provide significant avenues for increasing patient adherence and overall efficacy. This collection outlines the opportunity and identifies strategies for gaining regulatory approval.

• Formulation Development From Preclinical To First-In-Human

  A compound with poor biopharmaceutical properties or improper formulation design could lead to a delay in the project or even program termination.

• Wet Milling Vs. Dry Milling In The Pharmaceutical Industry

  Read about the considerations necessary for choosing between wet milling and dry milling for a specific active pharmaceutical ingredient.

• Contract Design And Development Vs. In-House: How To Find The Best Fit

  Explore the rationale behind opting for a contract development organization (CDO) to fulfill organizational requirements and underscore vital considerations for evaluating CDOs to ensure alignment with your project objectives.

• Microphysiological Systems: Closing The Gap Between Models And Medicine

  Microphysiological systems (MPS) use human cells to model tissue function, offering faster, more predictive insights for drug discovery, safety testing, and personalized medicine—bridging gaps left by animal and 2D models.